INS and Alzheimer disease: This metalloprotease, that also catabolizes insulin and IGF-1, can be competitively inhibited by insulin resistance [30, 46, 126, 200, 218, 238, 278], impairing Aβ degradation, increasing its neurotoxicity and promoting AD [11, 46, 278].